Clinical News - Page 1

Inhaled Parkinson’s drug shows positive results
Monday, January 09, 2012 An inhaled drug for the treatment of Parkinson's disease has shown positive results in a Phase I clinical trial, US-based Civitas Therapeutics has...

Hepatitis C vaccine trial shows positive results
Thursday, January 05, 2012 A hepatitis C vaccine has shown positive results in an early clinical trial, UK researchers have...

Actavis to launch new pain drug in the US
Friday, December 23, 2011 Actavis Inc has entered into a partnership with QRxPharma to commercialise MoxDuo IR in the...

FDA awards Catalyst cocaine dependency drug fast-track status
Wednesday, December 21, 2011 Catalyst Pharmaceutical Partners has received fast-track designation from the US food and Drug Administration (FDA) for CPP-115, a novel drug to treat cocaine...

AstraZeneca compounds now available to UK researchers
Thursday, December 15, 2011 A landmark agreement between the UK Medical Research Council (MRC) and AstraZeneca will allow researchers free access to a number of high potential...

UK cancer treatment costs to spiral by 2021
Thursday, December 15, 2011 The costs associated with the diagnosis and treatment of cancer in the UK will dramatically increase by 2021, according to a new report published by private healthcare provider...

Vaximm to launch first oral cancer vaccine study
Tuesday, December 13, 2011 Vaximm AG will start a clinical trial on the first ever investigational oral cancer vaccine, the company announced...

Cancer Research UK begins Stratified Medicine Programme enrolment
Tuesday, November 22, 2011 Cancer Research UK has enrolled the first 240 patients in its Stratified Medicine Programme, designed to create a multi-gene testing panel for oncology...

Breast cancer organisation awards research grants worth $2m
Friday, November 18, 2011 Susan G Komen for the Cure, a breast cancer organisation, has awarded $2m to researchers in Maryland,...

US drug shortages limited to generic injectables
Thursday, November 17, 2011 Prescription drug shortages in the US are primarily limited to generic injectables, but are increasing concern according to a new study produced by the IMS Institute for Healthcare...

Malaria blood entry route discovered by UK scientists
Thursday, November 10, 2011 Researchers in the UK have found a key weakness in the way the most deadly species of the malaria parasite enters human blood cells, offering new hope for vaccine...

US drug approval rates higher than ever
Friday, November 04, 2011 Over the past 12 months, the US Food and Drug Administration (FDA) approved 35 new medicines, the second highest approval rate this...

Transgene vaccine trial gives hope to lung cancer patients
Tuesday, October 25, 2011 The combination of a lung cancer vaccine plus chemotherapy has been proven to help more patients live without their cancer progressing than chemotherapy alone, a study has...

GSK malaria vaccine trial brings hope to African children
Wednesday, October 19, 2011 A vaccine developed by GlaxoSmithKline (GSK) and the PATH Malaria Vaccine Initiative has been shown to reduce the risk of malaria in African children by almost half in the first results of a...

Wide spread treatment distribution cuts Malaria by 20%
Tuesday, October 18, 2011 The number of deaths caused by malaria has decreased by more than 20% worldwide over the last decade, thanks to improved diagnostic testing and the increased availability of treatments, the...

Beta-blockers could bring hope to breast cancer patients
Monday, October 03, 2011 Scientists in Europe are investigating whether blood pressure drugs, known as beta-blockers, could prevent the spread of breast cancer and improve...

FDA remains concerned over birth control pill clot risk
Tuesday, September 27, 2011 The US Food and Drug Administration (FDA) has said that it remains concerned about the risk of blood clots with the use of drospirenone-containing birth control pills, including those made...

Tokai secures financing to advance TOK-001 drug study
Friday, September 23, 2011 Tokai Pharmaceuticals has raised $23m in a Series D3 financing to support the ongoing clinical development of galeterone (TOK-001), a treatment for castration-resistant prostate...

Inhibitex begins patient dosing in hepatitis C drug trial
Thursday, September 22, 2011 Inhibitex has started dosing in a Phase II clinical trial to assess the safety, tolerability and antiviral activity of INX-189 in treatment naive patients who have chronic hepatitis C...

SK biopharmaceuticals joins Mayo Clinic to develop sclerosis drug
Thursday, September 22, 2011 SK biopharmaceuticals has signed an agreement to collaborate with the Mayo Clinic for the discovery of new drugs targeting amyotrophic lateral sclerosis, also known as Lou Gehrig's...